Richard Barry Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard Barry.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard Barry. Richard Barry is Director in Sarepta Therapeutics, Inc. ($SRPT) and 10% Owner in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in MIMEDX GROUP, INC. ($AYXC.OB).
Latest Insider Trading Transactions of Richard Barry
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MBVX, AYXC.OB, SRPT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 2,726 | 0 | 3,125,366 | 3.1 M to 3.1 M (+0.09 %) |
Aug 07 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 159.09 | 3,140 | 499,543 | 3,129,140 | 3.1 M to 3.1 M (-0.10 %) |
Aug 07 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 158.43 | 26,860 | 4,255,430 | 3,132,280 | 3.2 M to 3.1 M (-0.85 %) |
Aug 06 2020 | AYXC.OB | MIMEDX GROUP, INC. | Barry Richard | Director | Grant | A | 0.00 | 38,135 | 0 | 3,338,135 | 3.3 M to 3.3 M (+1.16 %) |
May 15 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 142.05 | 4,673 | 663,800 | 3,159,140 | 3.2 M to 3.2 M (-0.15 %) |
May 15 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 141.12 | 25,327 | 3,574,146 | 3,163,813 | 3.2 M to 3.2 M (-0.79 %) |
May 15 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 142.05 | 4,673 | 663,800 | 3,159,140 | 3.2 M to 3.2 M (-0.15 %) |
May 15 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 141.12 | 25,327 | 3,574,146 | 3,163,813 | 3.2 M to 3.2 M (-0.79 %) |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 2,075 | 0 | 3,189,140 | 3.2 M to 3.2 M (+0.07 %) |
Sep 16 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 87.49 | 3,309 | 289,504 | 3,187,065 | 3.2 M to 3.2 M (+0.10 %) |
Sep 16 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 87.49 | 1,691 | 147,950 | 3,183,756 | 3.2 M to 3.2 M (+0.05 %) |
Aug 20 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 99.32 | 5,000 | 496,593 | 3,182,065 | 3.2 M to 3.2 M (+0.16 %) |
Aug 13 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 122.50 | 1,300 | 159,250 | 3,173,365 | 3.2 M to 3.2 M (+0.04 %) |
Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 1,633 | 0 | 3,172,065 | 3.2 M to 3.2 M (+0.05 %) |
Jun 29 2018 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Sell | S | 130.34 | 75,000 | 9,775,500 | 3,170,432 | 3.2 M to 3.2 M (-2.31 %) |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 3,418 | 0 | 3,245,432 | 3.2 M to 3.2 M (+0.11 %) |
Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 32.63 | 12,350 | 402,981 | 12,350 | |
Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 1,000 | 0 | 3,242,014 | 3.2 M to 3.2 M (+0.03 %) |
Mar 16 2016 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 15.66 | 75,000 | 1,174,185 | 3,241,014 | 3.2 M to 3.2 M (+2.37 %) |
Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 13.71 | 10,500 | 143,955 | 10,500 | |
Mar 02 2016 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 1,000 | 0 | 3,166,014 | 3.2 M to 3.2 M (+0.03 %) |
Jun 04 2015 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 25.18 | 9,746 | 245,404 | 9,746 | |
Dec 19 2012 | MBVX | MABVAX THERAPEUTIC ... | Barry Richard | 10% Owner | Sell | S | 1.86 | 48,390 | 90,049 | 243,800 | 292.2 K to 243.8 K (-16.56 %) |
Dec 14 2012 | MBVX | MABVAX THERAPEUTIC ... | Barry Richard | 10% Owner | Sell | S | 2.31 | 40,920 | 94,664 | 292,200 | 333.1 K to 292.2 K (-12.28 %) |
Dec 14 2012 | MBVX | MABVAX THERAPEUTIC ... | Barry Richard | 10% Owner | Sell | S | 1.87 | 61,798 | 115,803 | 292,200 | 354 K to 292.2 K (-17.46 %) |
Page: 1